<DOC>
	<DOCNO>NCT02601807</DOCNO>
	<brief_summary>The ActiPatch cutaneous device CE mark approved relief pain . It tap affected area stimulation high frequency report alleviate pain sensation . However class 1 evidence back pain . By randomise patient application active device dummy device assessment disability pain score two week , efficacy otherwise establish . Low back pain major health problem effective major economic implication device cheap safe .</brief_summary>
	<brief_title>ActiPatch Therapy Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<criteria>Participant willing able give inform consent participation trial . In Investigator 's opinion , able willing comply trial requirement . Willing allow General Practitioner consultant , appropriate , notified participation trial . Male female age 1890 year old stable chronic low back pain ≥3 month duration chronic low back pain current VAS pain rating ≥5/10 radiate pain knee ≥75 % back buttock pain rather low extremity pain Able complete tolerate treatment study period . Female participant pregnant Significant renal hepatic impairment . Prior home use pulse shortwave therapy Prior history spinal fusion fail spinal surgery syndrome . Laminectomy , laminotomy discectomy within 12 month enrollment . Diagnostic interventional injection low back surgery mention , include radiofrequency neuroablation within 6 month enrollment . Any addition strong opiate , pregabalin gabapentin treatment regime course trial Current implant cardiac demand pacemaker , defibrillator , cardiac pump , spinal stimulators implant electronic device . Patients use personal home base electrical stimulation device Patients concomitant illness ( e.g. , malignancy , osteoporosis ) , opinion investigator , would preclude successful patient participation also exclude Active psychiatric disorder ( evidence use antipsychotic medication ) . Patients diagnose history significant mood disorder exclude ( depression anxiety adequate control would acceptable ) . Scheduled elective surgery procedure require general anaesthesia trial . Participant life expectancy le 6 month , inappropriate placebo medication . Any significant disease disorder , opinion Investigator , may either put participant risk participation trial , may influence result trial , participant 's ability participate trial . Participants participate another research trial involve investigational product past 12 week . Participants able understand verbal write English , adequate translation/interpretation readily obtain .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Back</keyword>
	<keyword>Pain</keyword>
	<keyword>PSWT</keyword>
	<keyword>ActiPatch</keyword>
	<keyword>Pulsed shortwave therapy</keyword>
</DOC>